Abstract
Introduction and objectives: determine the prevalence and diagnostic concordance between the methods used for classification of metabolic syndrome: WHO, ATPIII, IDF, AACE, in diabetic patients of primary care programs in Bogotá. Materials and methods: cross-sectional study in 2.227 patients with type 2 diabetes and metabolic syndrome diagnostic agreement by four methods (WHO, ATPIII, IDF, AACE). Results: the prevalence of metabolic syndrome showed variability between WHO criteria (43.1%), ATP III (61.2%), AACE (65.6%) and IDF (90.5%) found gender differences, with a higher prevalence in women in 3 (WHO, ATPIII, IDF) of the 4 criteria for diagnosis of metabolic syndrome (p <0.001, chi-square test). Significant diagnostic correlation was found between ATPIII with the other 3 criteria and between WHO and IDF (p <0.001). The agreement obtained was higher with WHO ATPIII and IDF and between IDF with AACE. The concordance classification of metabolic syndrome (+) was more than 95% between IDF and ATPIII with between WHO and IDF and without metabolic syndrome classification (-), was greater agreement between ATPIII and WHO, other comparisons were less than 50%. Conclusions: the risk of cardiovascular disease in type 2 diabetic patients by the IDF classification is higher when using the IDF classifications with ATPIII and AACE. The highest diagnostic concordance of metabolic syndrome found between ATP III and WHO was determined as moderate. Classification of positive cases of metabolic syndrome is higher between ATPIII with IDF and between WHO and IDF.
References
Grundy S.M. Metabolic Syndrome Pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629-636 https://doi.org/10.1161/ATVBAHA.107.151092
Alberti K, Eckel R, Grundy S.M, Zimmet P, Cleeman J, Donato K, Fruchart J.C, James P, Loria C, Smith S. Harmonizing the Metabolic Syndrome. Circulation. 2009; 120:1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Paternina-Caicedo A, Alcalá-Cerra G, Paillier- Gonzales J, Romero-Zarante Á, Alvis-Guzmán N. Agreement between three definitions of metabolic syndrome in hypertensive patients. Rev. Salud pública. 11: 898-908, 2009. https://doi.org/10.1590/S0124-00642009000600006
Barbosa J.B, Moura da Silva A.A, Síndrome Metabólico en Ambulatorio Cardiológico. Arq Bras Cardiol 2010; 94: 44-51 https://doi.org/10.1590/S0066-782X2010000100009
Cerezo G. Características del síndrome metabólico en la consulta cardiológica. Insuficiencia Cardiaca. 2008 Vol. 3, Nº 1:11-15
Hernández Mijares A, Riera Fortuny C, Martínez Triguero M, Morillas Ariño C, Cubells Cascales P, Morales Suárez-Varela M. Metabolic Syndrome in Patients With
Coronary Heart Disease. Results of Using Different Diagnostic Criteria. Rev Esp Cardiol 2004;57:889-93 https://doi.org/10.1016/S1885-5857(06)60655-5
Rodríguez Bernardino A., García Polavieja P., Reviriego Fernández J., Serrano Ríos M. Prevalencia del síndrome metabólico y grado de concordancia en su diagnóstico en pacientes con diabetes mellitus tipo 2 en España; Endocrinol Nutr.2010;57:60-70" https://doi.org/10.1016/j.endonu.2009.12.002